The Addition of Bevacizumab in the First-Line Treatment for Metastatic Colorectal Cancer: An Updated Meta-Analysis of Randomized Trials

Oncotarget - United States
doi 10.18632/oncotarget.20314
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Metastatic Colorectal Cancer First-Line Treatment With Bevacizumab: The Impact of K-Ras Mutation

OncoTargets and Therapy
OncologyPharmacology
2013English

Discontinuation of First-Line Bevacizumab in Metastatic Colorectal Cancer: The BEAWARE Italian Observational Study

Tumori
MedicineCancer ResearchOncology
2019English

Cetuximab in First Line Treatment of Metastatic Colorectal Cancer

Farmeconomia. Health economics and therapeutic pathways
2012English

Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Critical Appraisal of Bevacizumab in the Treatment of Metastatic Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2012English

Meta-Analysis of Randomized Trials on First Line and Adjunctive Levetiracetam

Canadian Journal of Neurological Sciences
MedicineNeurology
2011English

Bevacizumab in First-Line Treatment of Elderly Patients With Metastatic Colorectal Cancer: German Community-Based Observational Cohort Study Results

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Bevacizumab-Based Chemotherapy and Thrombotic Events Risk in Colorectal Cancer Patients: A Meta-Analysis Study of Randomized Controlled Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Capecitabine Plus Oxaliplatin Compared With 5-Fluorouracil Plus Oxaliplatin in Metastatic Colorectal Cancer: Meta-Analysis of Randomized Controlled Trials

Oncology Letters
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy